Item 1. Report to
Shareholders
Institutional Small-Cap Stock Fund
|
December
31, 2013
|
-
Small-cap shares generated stellar returns in
2013 amid improving fundamentals and a momentum-driven rally during a
continued low interest rate
period.
-
The fund enjoyed extraordinary returns for
the year.
-
The markets strong gains in the past six
months prompted us to trim or sell companies whose valuations became
stretched or exceeded our small-cap market
capitalization ranges.
-
Valuations of small-caps have been driven
sharply higher, and we would advise investors to adjust their
expectations
about future gains and
recognize the importance of diversification to meet their long-term financial
goals.
The views and opinions in this report
were current as of December 31, 2013. They are not guarantees of performance or
investment results and should not be taken as investment advice. Investment
decisions reflect a variety of factors, and the managers reserve the right to
change their views about individual stocks, sectors, and the markets at any
time. As a result, the views expressed should not be relied upon as a forecast
of the funds future investment intent. The report is certified under the
Sarbanes-Oxley Act, which requires mutual funds and other public companies to
affirm that, to the best of their knowledge, the information in their financial
reports is fairly and accurately stated in all material respects.
Managers Letter
T. Rowe Price Institutional Small-Cap Stock
Fund
Dear Investor
Small-cap stocks generated stellar
gains in 2013, rising 38.82%, the fourth-best return since the inception of the
Russell 2000 Index in 1979. Our Institutional Small-Cap Stock Fund rose 39.56%,
outperforming the indexs strong returns and competitive funds as measured by
the Lipper Small-Cap Core Funds Index.
The Institutional Small-Cap Stock
Fund gained 39.56% in 2013, compared with 38.82% for the Russell 2000 Index and
36.13% for the Lipper Small-Cap Core Funds Index. The fund gained 19.87% in the
last six months, outperforming the Russell 2000 and the peer group index. Based
on cumulative total return, Lipper ranked the Institutional Small-Cap Stock Fund
in the top 10% of small-cap core funds in the 3-, 5-, and 10-year periods ended
December 31, 2013. Lipper ranked the Institutional Small-Cap Stock Fund 212 of
718, 62 of 646, 35 of 591, and 23 of 352 small-cap core funds for the 1-, 3-,
5-, and 10-year periods ended December 31, 2013, respectively. (Results will
vary for other periods.
Past performance
cannot guarantee future results
.)
Where did such strong performance
come from? Similar to 2003, the lowest-quality and highest-risk small-caps
outperformed higher-quality stocks, according to a study by Bank of America
Merrill Lynch, which measured returns based on liquidity, earnings, and growth
rates.
The Russell 2000 Index historically
has followed strong market returns with further appreciation in the subsequent
calendar year, and, as we write, the U.S. economy appears to be reaccelerating,
our firms continue to see improvements in European economies, and China looks as
if it will continue to grow, thus giving us a constructive backdrop for
equities.
Our greatest concern remains extended
valuations in small-caps. The asset class is richly priced, value is hard to
find, and a decade or more of limited initial public offering (IPO) activity has
more dollars chasing fewer
names. With that
backdrop, we would caution investors not to expect future returns to match the
extraordinary gains of 2013. We continue to be cautious in the small-cap space,
and our concerns are detailed in the Outlook section of this letter.
Performance Review
For the six-month period, our best
sector returns included financials, health care, industrials and business
services, and energy. Problem sectors included consumer discretionary; consumer
staples; and materials, where stock selection hindered performance.
In financials, healing credit
markets, a resumption of loan growth, and rising markets had positive effects on
our holdings. Five years after the financial crisis, the market has finally
begun to discount an end to the Feds quantitative easing program. As rates rise
with the improving business cycle, asset-sensitive banks can earn stronger
returns.
Signature Bank
,
Western Alliance
Bancorp
, and
Texas Capital Bancshares
all fit this mold, and their shares rose strongly. Signature Bank rose
on solid earnings amid better loan growth than its peers and favorable
indications for future deposit and loan growth. Western Alliance and Texas
Capital generated strong gains, as both banks have seen improving credit trends.
Texas Capital is experiencing good loan growth in its specialty finance
business. Healing credit is also a theme that plays into the strong recovery
experienced by
E*TRADE
Financial
, which gained on better credit
metrics in its mortgage and home equity holdings. Moreover, the firm has won
approval from regulators to distribute $100 million of excess capital to the
holding company. Rising capital markets also presented a strong tailwind for
several of our holdings, notably
Waddell
& Reed Financial
and
Financial Engines
, a top holding in the portfolio. Waddell & Reed reported strong
earnings, and its assets under management exceeded expectations. Financial
Engines, which provides financial advice to corporate plan participants, also
experienced strong asset growth. We expect promising growth in its retirement
income solutions business. (Please refer to the portfolio of investments for a
complete list of holdings and the amount each represents in the portfolio.)
Health care shares turned in another strong performance.
Incyte
continued
to exceed expectations with its drug Jakafi, for treatment of patients with
myelofibrosis. Incyte is also seeking U.S. Food and Drug Administration approval
of Jakafi for treatment of polycythemia vera, a rare blood disorder. Its
recently released data on pancreatic cancer suggests that Jakafi may also have
the potential to treat other challenging solid tumors.
Pacira Pharmaceuticals
nearly doubled, as its non-opioid
painkiller Exparel continued to gain momentum. This injectable,
long-acting medication has cut opioid use; hospital stays; and, consequently,
hospital costs for patients.
Among industrials and business
services,
Acuity Brands
generated solid gains, as its LED lighting products had
brisk sales amid a rebound in new commercial construction. The nonresidential
construction market is in the early phases of a recovery, with square footage
growing 40% slower than its long-term trend. Maintenance equipment manufacturer
Toro
generated strong gains despite challenging weather conditions compared
with the previous year. The firm signaled its continued confidence by
significantly increasing its dividend. Toro has a long history of accretive
share repurchases.
Longtime utility holding
UNS Energy
agreed to be acquired by Fortis for a 30% premium to its
trading price. As we dont foresee competing bids, we have begun trimming the
position. Energy stocks also added value in the second half of the year.
Clayton Williams Energy
rose briskly as the firm appears to have excellent
acreage positions in the sought-after Wolfcamp shale gas development in the
Permian Basin. Many theorize this acreage could have strategic value to an
acquirer.
Consumer discretionary was a drag on
relative performance in the past six months due to stock selection. We lost
money in
Francescas
Holdings
,
BJs Restaurants
,
Tile Shop Holdings
, and clothing retailer
Express
. Francescas fell after
the firm experienced disappointing traffic and significant declining same-store
sales in its gifting category. Mall traffic clearly disappointed during the
holiday season, and Francescas modest Internet offerings could not offset
declining brick-and-mortar traffic. BJs Restaurants declined as same-store
sales and traffic also disappointed. Management hopes to reverse this trend with
menu innovation. Tile Shop Holdings declined as the stock was the subject of
several aggressive reports alleging accounting manipulation and management
self-dealing. Tile Shop Holdings has high margins, as the ceramic tile market is
quite opaque. Indeed, it is difficult for consumers to engage in effective
competitive price discovery. We are monitoring the situation closely but holding
on for now. Express reported disappointing trends in November due to traffic
weakness. Weak sales have led to high inventory levels, further depressing the
shares. One of the few bright spots in the sector was recreational boat maker
Brunswick
, which rose on the continued recovery in the industry. Brunswick
recently laid out a multiyear plan for new product development and strong
earnings growth.
We have historically had a hard time
finding value in the consumer staples sector, and 2013 was no exception. The
sector performed exceptionally well, and we were underweight the group.
Fresh Market
declined, as weaker-than-expected results in new markets
raised questions about store productivity and the validity of the firms real
estate strategy.
Materials also lagged, as we were
hurt by exposure to
Compass
Minerals
, which produces rock salt and
nutrient potassium sulfate for crops. The potash market has been in turmoil
following the breakup of a Russian cartel. While this hasnt depressed potassium
sulfate prices yet, volume has dropped as farmers are awaiting a possible price
break. Moreover, the season was slower than expected, and southern U.S.
customers remain flush with inventories following a few mild winters. If
Maryland is any indication of the winter of 20132014, this may be a short-term
problem. We were also hurt in this segment as we prematurely eliminated our
position in
AK Steel
. AK is highly levered, and the stock gained strongly
after announcing steel price increases.
In the technology sector, we were
hurt by disappointing results in
Angies
List
,
Semtech
, and
RealD
. Angies
List fell after the firm reported mixed earnings results and issued tepid
revenue and earnings expectations. The firm was also testing lower price points
in selected markets, which generated negative press accounts. Semtech declined
after the power management chip firm experienced a disappointing product cycle
for a new chip tied to the Samsung Galaxy S4 phone. RealD declined on
disappointing results for its 3-D movie products. Cinema licensing did not
reaccelerate as planned, and the slate of movies released in the second half of
the year performed below expectations. We decided to eliminate the holding. One
standout in the technology sector was
SS&C Technologies Holdings
, a
financial services software firm that offers asset management accounting
platforms. Management has positioned the firm for solid organic growth and has
executed on a number of attractive acquisitions. The Board of Directors also
recently authorized a $100 million share repurchase program.
Portfolio Review
On the Buy Side
Our largest purchase in the past six
months was
Krispy Kreme
. We believe the company is in the early innings of a
turnaround story that could drive a significant expansion in efficiencies and
lead to years of growth. Krispy Kreme is an iconic American
brand but has failed to live up to its high expectations following its IPO. New
management has a vision of a smaller-format store with improved economics, which
should improve returns for franchisees in new geographies.
Our second-largest addition was also
a new initiation of a previous holding that is now under new transformational
management.
Mobile Mini
buys used steel ocean-shipping containers, refurbishes
them, and leases them primarily to construction companies as portable storage
containers throughout locations in the U.S. and the UK. New CEO Erik Olsson has
led turnarounds of larger and more complex leasing companies. We believe he can
implement a culture of constant improvement and drive margins and returns
higher.
On the value side of the portfolio,
we added new holdings in
Constellium
and
Berry Plastics
.
Constellium is a downstream aluminum producer of fabricated parts for the
aerospace, automotive, and packaging markets. Aerospace exposure is with Airbus
and involves high-margin, long-term contracts. The company could benefit from
the shift from steel to aluminum among automakers. Berry Plastics is a leading
domestic supplier of rigid and flexible packaging products. We like the
companys consistent free cash generation and its innovative new thermoform cup.
The company is an active consolidator in its industry, and its significant cash
flow can be used to either deliver the balance sheet or fund intriguing
acquisitions.
In the energy sector, we added two
exploration and production firms and the independent power producer
Dynegy
. Dynegy is a highly levered play on rising natural gas prices. The
company emerged from bankruptcy last fall with an improved net debt position and
strong free cash flow. The firm has a fleet of Illinois coal-fired plants, which
is supplemented by the recent purchase of Amerens coal fleet at bargain prices.
The stock has been under pressure due to the Obama administrations carbon
initiatives, but we believe the sell-off has been overdone.
EPL Oil & Gas
is a proven operator in the shallow Gulf of Mexico, which has been out of
favor with investors given its high well decline rates and heavy natural gas
exposure. The advent of better seismic indicators allows petroleum engineers to
see and drill deeper and to potentially drive better-than-expected growth in the
Gulf. The stock appeared very cheap on a 2014 cash flow basis. In a related
play,
Energy XXI Bermuda
is a shallow Gulf producer that is applying horizontal
drilling and seismic indicators to generate more growth than the market
appreciates from its assets, which have historically been out of favor due to
its wells perceived high decline rates and high gas exposure. The company had
some execution challenges that are likely improving and has a call option on
ultra-deep Gulf gas.
Other interesting new investments
included
PS Business
Parks
and
Pinnacle Foods
.
We initiated a position in PS Business Parks earlier in the year as we believe
the company will drive above-average cash flow growth through the lease of
existing assets, several of which were recently acquired at attractive
prices. In addition, with a strong history of capital allocation, a solid
balance sheet, and a reasonable valuation, we believe PS Business has the
potential to produce good risk-adjusted returns over the medium term.
In December, we added to Pinnacle
Foods, a position we initiated through the companys March 2013 IPO. Pinnacle is
a well-run consolidator in the North American food industry, with solid
positions in frozen vegetables and baking mixes. In October 2013, Pinnacle
closed the acquisition of the Wishbone salad dressing business, and we
participated in a follow-on offering of Pinnacle shares in December. Pinnacle
has been a strong holding since the IPO and continues to execute its strategy
well.
On the Sell Side
We significantly cut or eliminated
several longtime holdings following huge runs in the stock price. We eliminated
our position in
3D
Systems
. 3-D printing has captured
investors imaginations, and our shares had appreciated more than tenfold. Given
valuation and market capitalization issues, we sold the shares.
Similarly, we trimmed
Regeneron Pharmaceuticals
, as its market cap continued to increase following the launch of its new
therapy for macular degeneration, Eylea, significantly exceeding investors
expectations. Although we have a favorable long-term view of Eylea and
Regenerons drug pipeline, heightened Wall Street expectations have moderated
the risk/reward balance in the stock.
Insurer
Markel
has been a
longstanding holding in our portfolio, and we benefited from the companys
strong track record. Following the recent acquisition of competitor Alterra, the
company now qualifies as a mid-cap and the acquisition modestly increases our
risk profile. Therefore, we have been selling the stock.
Following its strong performance and
position size, we trimmed Acuity to manage the position size. As is typical,
merger and acquisition (M&A) activity led to further trading in the second
half of the year. As noted earlier, we sold part of our stake in UNS Energy,
given that the company is in the process of being acquired by Canada-based
utility Fortis. Similarly, we eliminated
ONYX Pharmaceuticals
following
its acquisition by Amgen, while
Optimer
Pharmaceuticals
was acquired by
Cubist Pharmaceuticals
.
With valuations looking quite
stretched in the technology sector following its extraordinary performance, we
have significantly reduced our exposure. Indeed, weve learned the hard lesson
that it is better to sell on the way up than to try to pick the top exit with
the crowd.
Splunk
is a high-quality enterprise software company that is a
big data play on collecting and analyzing data from many sources, including
Web applications and mobile devices. We think the company has bright prospects,
but we reduced our position as valuations became stretched.
Concur Technologies
, like Splunk, is a high-quality enterprise software company offering
e-commerce solutions. Concur has an easy-to-use cloud-based application that has
captured investors attention. Its rich valuation led us to trim.
We also cut exposure to
Synaptics
, given its strong year-to-date share gains in mobile devices. It offers
touchscreen interface solutions for mobile devices and computers. We believe
growth will decelerate and margins will decline as competition rises. Our bias
is to trim on strength.
We sold
Bankrate
after a
recovery in business fundamentals and a recent CEO departure. While we have
confidence in the companys strategy and believe the recovery in the insurance
segment will provide a tailwind to the business in 2014, we tend to be cautious
about management transitions. We took advantage of recent strength in the stock
to reduce our position.
Outlook
Last year was truly exceptional for
domestic small-cap stock investors. Though we can be pleased with returns, we
would caution investors not to expect future returns to match the extraordinary
gains of 2013. Market momentum, though, can typically remain in place for a
while, thus big years such as those experienced in 2013 are often followed by
reasonably positive returns in subsequent 12-month periods. The U.S. economy
appears to be strengthening, boding well for domestic stocks. Europe is also
showing signs of life, further boosting management confidence.
Favorable fund flows benefited our
small-cap market. In fact, our sector is truly experiencing a premium valuation
based on scarcity value. From 1999 through the end of 2013, the number of
publicly traded firms in the Wilshire 5000 Total Market Index fell from more
than 7,000 to more than 3,700. Years of M&A activity, management leveraged
buyouts, and financial distress have thinned the ranks of public firms.
Moreover, the number of IPOs has plummeted in the ensuing decade, with the
advent of Sarbanes-Oxley compliance requirements. The result is more dollars
chasing fewer public companies.
Naturally this has driven small-cap
valuations sharply higher. Frankly, these rich valuations concern us.
Price/earnings (P/E) ratios have now eclipsed 2007 highs, exceeding 19X forward
earnings. Merrill Lynch notes in a recent study that these valuations are now
greater than one standard deviation above the norm. Moreover, our good friend
Lori Calvasina, a Credit Suisse small- and mid-cap equity strategist, notes
that valuations on a price-to-sales ratio of 1.53 for the Russell 2000 Index are
near all-time highs, making further appreciation a challenging
matter.
Also, earnings expectations for the
small-cap space are quite elevated, opening up the possibility of negative
revisions and investor disappointment. Finally, to the extent global economies
continue to recover, the backdrop for large companies earnings should finally
improve. All these points lead us to continue to believe that large-caps will
outperform small-caps in the coming periods.
While we dont expect small-cap
stocks to experience sharp depreciation, we do expect them to underperform
large-cap companies. We could easily foresee a period
similar to the mid-1990s, in which even in a rising
economy, the small-cap sector experienced years of P/E compression and trailing
returns versus the S&P 500 Index. We would strongly advise you to review
your allocations to small-cap funds and consider reducing holdings in the space,
particularly if you find yourself overweight in the asset class after this
period of strong performance.
As always, thank you for continuing
to express your confidence in us by investing in the Institutional Small-Cap
Stock Fund.
Greg A. McCrickard
President of the fund and chairman of its Investment
Advisory Committee
January 17, 2014
The committee chairman has
day-to-day responsibility for managing the portfolio and works with committee
members in developing and executing the funds investment
program.
Fund Closed to New
Investors
|
On January 2, 2014, T. Rowe Price
closed its Institutional Small-Cap Stock
Fund to new investors in order to protect the interests of the funds existing
shareholders. Existing shareholders in the fund may continue to buy, exchange,
and sell shares in accordance with our existing fund policies. The Institutional
Small-Cap Stock Fund, along with the Small-Cap Stock Fund, had grown
considerably through the end of 2013, and continuing to allow new investors to
invest in the funds could have compromised the portfolio managers ability to
select and hold the small-cap stocks that offer the best opportunities for
long-term returns. T. Rowe Price first closed the Institutional Small-Cap Stock
Fund in March 2004 and reopened the fund in April 2009. Given the recent very
strong returns for small-cap stocks in general, we suggest that you review your
allocation to small-cap companiesas well as your investment time horizonand
consider reducing the size of these holdings if they have grown to a
larger-than-expected proportion of your overall portfolio.
As with all stock and bond mutual
funds, the funds share price can fall because of weakness in the stock or bond
markets, a particular industry, or specific holdings. The financial markets can
decline for many reasons, including adverse political or economic developments,
changes in investor psychology, or heavy institutional selling. The prospects
for an industry or company may deteriorate because of a variety of factors,
including disappointing earnings or changes in the competitive environment. In
addition, the investment managers assessment of companies held in a fund may
prove incorrect, resulting in losses or poor performance even in rising markets.
Investing in small companies involves greater risk than is customarily
associated with larger companies. Stocks of small companies are subject to more
abrupt or erratic price movements than larger-company stocks. Small companies
often have limited product lines, markets, or financial resources, and their
managements may lack depth and experience. Such companies seldom pay significant
dividends that could cushion returns in a falling market.
Basis point:
One
one-hundredth of one percentage point, or 0.01%.
Lipper indexes:
Fund benchmarks that consist of a small number of the
largest mutual funds in a particular category as defined by Lipper
Inc.
Market capitalization:
The total value of a companys publicly
traded shares.
Price/book ratio:
A valuation measure that compares a stocks market price
with its book value; i.e., the companys net worth divided by the number of
outstanding shares.
Price/earnings (P/E) ratio:
A valuation measure calculated by
dividing the price of a stock by its reported earnings per share. The ratio is a
measure of how much investors are willing to pay for the companys
earnings.
Price/sales ratio:
A valuation measure calculated by
dividing the price of a stock by its current or projected (forward) sales (or
revenues) per share.
Return on equity (ROE):
Calculated by dividing a companys net
income by shareholders equity, ROE measures how much a company earns on each
dollar that common stock investors have put into that company. ROE indicates how
effectively and efficiently the company and its management are using
stockholder investments.
Russell 2000 Growth Index:
A market-weighted total return index
that measures the performance of companies within the Russell 2000 Index having
higher price/book value ratios and higher forecast growth rates.
Russell 2000 Index:
An unmanaged index that tracks the
stocks of 2,000 small U.S. companies.
Russell 2000 Value Index:
An index that tracks the performance of
small-cap stocks with higher price/book ratios and higher forecast growth
values.
S&P 500 Index:
An unmanaged index that tracks the
stocks of 500 primarily large-cap U.S. companies.
Wilshire 5000 Total Market Index:
An index that measures the performance
of all U.S. equity securities with readily available price data.
Note: Russell Investment Group is the
source and owner of the trademarks, service marks, and copyrights related to the
Russell indexes. Russell
®
is a trademark of Russell Investment
Group.
Portfolio
Highlights
Performance and
Expenses
T. Rowe Price Institutional
Small-Cap Stock Fund
This table shows the value of a
hypothetical $1 million investment in the fund over the past 10 fiscal year
periods or since inception (for funds lacking 10-year records). The result is
compared with benchmarks, which may include a broad-based market index and a
peer group average or index. Market indexes do not include expenses, which are
deducted from fund returns as well as mutual fund averages and
indexes.
Fund Expense Example
As a mutual fund shareholder, you may
incur two types of costs: (1) transaction costs, such as redemption fees or
sales loads, and (2) ongoing costs, including management fees, distribution and
service (12b-1) fees, and other fund expenses. The following example is intended
to help you understand your ongoing costs (in dollars) of investing in the fund
and to compare these costs with the ongoing costs of investing in other mutual
funds. The example is based on an investment of $1,000 invested at the beginning
of the most recent six-month period and held for the entire period.
Actual
Expenses
The first line of the
following table (Actual) provides information about actual account values and
actual expenses. You may use the information on this line, together with your
account balance, to estimate the expenses that you paid over the period. Simply
divide your account value by $1,000 (for example, an $8,600 account value
divided by $1,000 = 8.6), then multiply the result by the number on the first
line under the heading Expenses Paid During Period to estimate the expenses
you paid on your account during this period.
Hypothetical Example for
Comparison Purposes
The information
on the second line of the table (Hypothetical) is based on hypothetical account
values and expenses derived from the funds actual expense ratio and an assumed
5% per year rate of return before expenses (not the funds actual return). You
may compare the ongoing costs of investing in the fund with other funds by
contrasting this 5% hypothetical example and the 5% hypothetical examples that
appear in the shareholder reports of the other funds. The hypothetical account
values and expenses may not be used to estimate the actual ending account
balance or expenses you paid for the period.
You should also be aware that the
expenses shown in the table highlight only your ongoing costs and do not reflect
any transaction costs, such as redemption fees or sales loads. Therefore, the
second line of the table is useful in comparing ongoing costs only and will not
help you determine the relative total costs of owning different funds. To the
extent a fund charges transaction costs, however, the total cost of owning that
fund is higher.
Financial Highlights
T. Rowe Price Institutional Small-Cap Stock
Fund
The accompanying notes are an
integral part of these financial statements.
Portfolio of
Investments
T. Rowe Price Institutional Small-Cap Stock
Fund
December 31, 2013
The accompanying notes are an
integral part of these financial statements.
Statement of Assets and
Liabilities
T. Rowe Price
Institutional Small-Cap Stock Fund
December 31, 2013
($000s, except shares and per share
amounts)
The accompanying notes are an
integral part of these financial statements.
Statement of
Operations
T. Rowe Price
Institutional Small-Cap Stock Fund
($000s)
The accompanying notes are an
integral part of these financial statements.
Statement of Changes in Net
Assets
T. Rowe Price Institutional
Small-Cap Stock Fund
($000s)
The accompanying notes are an
integral part of these financial statements.
Notes to Financial
Statements
T. Rowe Price
Institutional Small-Cap Stock Fund
December 31, 2013
T. Rowe Price Institutional Equity
Funds, Inc. (the corporation), is registered under the Investment Company Act of
1940 (the 1940 Act). The Institutional Small-Cap Stock Fund (the fund) is a
diversified, open-end management investment company established by the
corporation. The fund commenced operations on March 31, 2000. The fund seeks to
provide long-term capital growth by investing primarily in stocks of small
companies.
NOTE 1 - SIGNIFICANT ACCOUNTING
POLICIES
Basis of Preparation
The fund is an investment company and
follows accounting and reporting guidance in the
Financial Accounting Standards Board
Accounting Standards Codification
Topic 946 (ASC 946). The accompanying financial statements were prepared in
accordance with accounting principles generally accepted in the United States of
America (GAAP), including but not limited to ASC 946. GAAP requires the use of
estimates made by management. Management believes that estimates and valuations
are appropriate; however, actual results may differ from those estimates, and
the valuations reflected in the accompanying financial statements may differ
from the value ultimately realized upon sale or maturity.
Investment Transactions,
Investment Income, and Distributions
Income and expenses are recorded on the accrual basis. Premiums and
discounts on debt securities are amortized for financial reporting purposes.
Dividends received from mutual fund investments are reflected as dividend
income; capital gain distributions are reflected as realized gain/loss. Dividend
income and capital gain distributions are recorded on the ex-dividend date.
Income tax-related interest and penalties, if incurred, would be recorded as
income tax expense. Investment transactions are accounted for on the trade date.
Realized gains and losses are reported on the identified cost basis.
Distributions to shareholders are recorded on the ex-dividend date. Income
distributions are declared and paid annually. Capital gain distributions, if
any, are generally declared and paid by the fund annually.
Currency Translation
Assets, including investments, and
liabilities denominated in foreign currencies are translated into U.S. dollar
values each day at the prevailing exchange rate, using the mean of the bid and
asked prices of such currencies against U.S. dollars as quoted by a major bank.
Purchases and sales of securities, income, and expenses are translated into U.S.
dollars at the prevailing exchange rate on the date of the transaction. The
effect of changes in foreign currency exchange rates on realized and unrealized
security gains and losses is reflected as a component of security gains and
losses.
Rebates and Credits
Subject to best execution, the fund may
direct certain security trades to brokers who have agreed to rebate a portion of
the related brokerage commission to the fund in cash. Commission rebates are
reflected as realized gain on securities in the accompanying financial
statements and totaled $22,000 for the year ended December 31, 2013.
Additionally, the fund earns credits on temporarily uninvested cash balances
held at the custodian, which reduce the funds custody charges. Custody expense
in the accompanying financial statements is presented before reduction for
credits.
In-Kind Subscriptions
Under certain circumstances, and when
considered to be in the best interest of the fund, the fund may accept portfolio
securities rather than cash as payment for the purchase of fund shares (in-kind
subscription). For financial reporting and tax purposes, the cost basis of
contributed securities is equal to the market value of the securities on the
date of contribution. In-kind subscriptions result in no gain or loss and no tax
consequences for the fund. During the year ended December 31, 2013, the fund
accepted $113,547,000 of in-kind subscriptions, including $98,082,000 from other
T. Rowe Price funds.
New Accounting Guidance
On January 1, 2013, the fund adopted new
accounting guidance, issued by the Financial Accounting Standards Board, that
requires an entity to disclose information about offsetting and related
arrangements to enable users of its financial statements to understand the
effect of those arrangements on its financial position. Adoption had no effect
on the funds net assets or results of operations.
NOTE 2 - VALUATION
The funds financial instruments are
valued, and its net asset value (NAV) per share is computed at the close of the
New York Stock Exchange (NYSE), normally 4 p.m. ET, each day the NYSE is open
for business.
Fair Value
The funds financial instruments are reported at fair
value, which GAAP defines as the price that would be received to sell an asset
or paid to transfer a liability in an orderly transaction between market
participants at the measurement date. The T. Rowe Price Valuation Committee (the
Valuation Committee) has been established by the funds Board of Directors (the
Board) to ensure that financial instruments are appropriately priced at fair
value in accordance with GAAP and the 1940 Act. Subject to oversight by the
Board, the Valuation Committee develops and oversees pricing-related policies
and procedures and approves all fair value determinations. Specifically, the
Valuation Committee establishes procedures to value securities; determines
pricing techniques, sources, and persons eligible to effect fair value pricing
actions; oversees the selection, services, and performance of pricing vendors;
oversees valuation-related business continuity practices; and provides guidance
on internal controls and valuation-related matters. The Valuation Committee
reports to the funds Board; is chaired by the funds treasurer; and has
representation from legal, portfolio management and trading, operations, and
risk management.
Various valuation techniques and
inputs are used to determine the fair value of financial instruments. GAAP
establishes the following fair value hierarchy that categorizes the inputs used
to measure fair value:
Level 1 quoted prices (unadjusted)
in active markets for identical financial instruments that the fund can access
at the reporting date
Level 2 inputs other than Level 1
quoted prices that are observable, either directly or indirectly (including, but
not limited to, quoted prices for similar financial instruments in active
markets, quoted prices for identical or similar financial instruments in
inactive markets, interest rates and yield curves, implied volatilities, and
credit spreads)
Level 3 unobservable
inputs
Observable inputs are developed using
market data, such as publicly available information about actual events or
transactions, and reflect the assumptions that market participants would use to
price the financial instrument. Unobservable inputs are those for which market
data are not available and are developed using the best information available
about the assumptions that market participants would use to price the financial
instrument. GAAP requires valuation techniques to maximize the use of relevant
observable inputs and minimize the use of unobservable inputs. When multiple
inputs are used to derive fair value, the financial instrument is assigned to
the level within the fair value hierarchy based on the lowest-level input that
is significant to the fair value of the financial instrument. Input levels are
not necessarily an indication of the risk or liquidity associated with financial
instruments at that level but rather the degree of judgment used in determining
those values.
Valuation Techniques
Equity securities listed or regularly
traded on a securities exchange or in the over-the-counter (OTC) market are
valued at the last quoted sale price or, for certain markets, the official
closing price at the time the valuations are made. OTC Bulletin Board securities
are valued at the mean of the closing bid and asked prices. A security that is
listed or traded on more than one exchange is valued at the quotation on the
exchange determined to be the primary market for such security. Listed
securities not traded on a particular day are valued at the mean of the closing
bid and asked prices for domestic securities and the last quoted sale or closing
price for international securities.
For valuation purposes, the last
quoted prices of non-U.S. equity securities may be adjusted to reflect the fair
value of such securities at the close of the NYSE. If the fund determines that
developments between the close of a foreign market and the close of the NYSE
will, in its judgment, materially affect the value of some or all of its
portfolio securities, the fund will adjust the previous quoted prices to reflect
what it believes to be the fair value of the securities as of the close of
the NYSE. In deciding whether it is
necessary to adjust quoted prices to reflect fair value, the fund reviews a
variety of factors, including developments in foreign markets, the performance
of U.S. securities markets, and the performance of instruments trading in U.S.
markets that represent foreign securities and baskets of foreign securities. The
fund may also fair value securities in other situations, such as when a
particular foreign market is closed but the fund is open. The fund uses outside
pricing services to provide it with quoted prices and information to evaluate or
adjust those prices. The fund cannot predict how often it will use quoted prices
and how often it will determine it necessary to adjust those prices to reflect
fair value. As a means of evaluating its security valuation process, the fund
routinely compares quoted prices, the next days opening prices in the same
markets, and adjusted prices.
Actively traded domestic equity
securities generally are categorized in Level 1 of the fair value hierarchy.
Non-U.S. equity securities generally are categorized in Level 2 of the fair
value hierarchy despite the availability of quoted prices because, as described
above, the fund evaluates and determines whether those quoted prices reflect
fair value at the close of the NYSE or require adjustment. OTC Bulletin Board
securities, certain preferred securities, and equity securities traded in
inactive markets generally are categorized in Level 2 of the fair value
hierarchy.
Debt securities generally are traded
in the OTC market. Securities with remaining maturities of one year or more at
the time of acquisition are valued at prices furnished by dealers who make
markets in such securities or by an independent pricing service, which considers
the yield or price of bonds of comparable quality, coupon, maturity, and type,
as well as prices quoted by dealers who make markets in such securities.
Generally, debt securities are categorized in Level 2 of the fair value
hierarchy; however, to the extent the valuations include significant
unobservable inputs, the securities would be categorized in Level 3.
Investments in mutual funds are
valued at the mutual funds closing NAV per share on the day of valuation and
are categorized in Level 1 of the fair value hierarchy. Assets and liabilities
other than financial instruments, including short-term receivables and payables,
are carried at cost, or estimated realizable value, if less, which approximates
fair value.
Thinly traded financial instruments
and those for which the above valuation procedures are inappropriate or are
deemed not to reflect fair value are stated at fair value as determined in good
faith by the Valuation Committee. The objective of any fair value pricing
determination is to arrive at a price that could reasonably be expected from a
current sale. Financial instruments fair valued by the Valuation Committee are
primarily private placements, restricted securities, warrants, rights, and other
securities that are not publicly traded.
Subject to oversight by the Board,
the Valuation Committee regularly makes good faith judgments to establish and
adjust the fair valuations of certain securities as events occur and
circumstances warrant. For instance, in determining the fair value of an equity
investment with limited market activity, such as a private placement or a thinly
traded public company stock, the Valuation Committee considers a variety of
factors, which may include, but are not limited to, the issuers business
prospects, its financial standing and performance, recent investment
transactions in the issuer, new rounds of financing, negotiated transactions of
significant size between other investors in the company, relevant market
valuations of peer companies, strategic events affecting the company, market
liquidity for the issuer, and general economic conditions and events. In
consultation with the investment and pricing teams, the Valuation Committee will
determine an appropriate valuation technique based on available information,
which may include both observable and unobservable inputs. The Valuation
Committee typically will afford greatest weight to actual prices in arms length
transactions, to the extent they represent orderly transactions between market
participants; transaction information can be reliably obtained; and prices are
deemed representative of fair value. However, the Valuation Committee may also
consider other valuation methods such as market-based valuation multiples; a
discount or premium from market value of a similar, freely traded security of
the same issuer; or some combination. Fair value determinations are reviewed on
a regular basis and updated as information becomes available, including actual
purchase and sale transactions of the issue. Because any fair value
determination involves a significant amount of judgment, there is a degree of
subjectivity inherent in such pricing
decisions, and fair value prices determined by the Valuation Committee
could differ from those of other market participants. Depending on the relative
significance of unobservable inputs, including the valuation technique(s) used,
fair valued securities may be categorized in Level 2 or 3 of the fair value
hierarchy.
Valuation Inputs
The following table summarizes the funds financial
instruments, based on the inputs used to determine their fair values on December
31, 2013:
There were no material transfers
between Levels 1 and 2 during the year.
Following is a reconciliation of the
funds Level 3 holdings for the year ended December 31, 2013. Gain (loss)
reflects both realized and change in unrealized gain/loss on Level 3 holdings
during the period, if any, and is included on the accompanying Statement of
Operations. The change in unrealized gain/loss on Level 3 instruments held at
December 31, 2013, totaled $548,000 for the year ended December 31, 2013.
Transfers into and out of Level 3 are reflected at the value of the financial
instrument at the beginning of the period. During the year, transfers out of
Level 3 were because observable market data became available for the
security.
NOTE 3 - OTHER INVESTMENT
TRANSACTIONS
Consistent with its investment
objective, the fund engages in the following practices to manage exposure to
certain risks and/or to enhance performance. The investment objective, policies,
program, and risk factors of the fund are described more fully in the funds
prospectus and Statement of Additional Information.
Restricted Securities
The fund may invest in securities that
are subject to legal or contractual restrictions on resale. Prompt sale of such
securities at an acceptable price may be difficult and may involve substantial
delays and additional costs.
Other
Purchases and sales of portfolio securities other than
short-term securities aggregated $474,453,000 and $258,573,000, respectively,
for the year ended December 31, 2013.
NOTE 4 - FEDERAL INCOME
TAXES
No provision for federal income taxes
is required since the fund intends to continue to qualify as a regulated
investment company under Subchapter M of the Internal Revenue Code and
distribute to shareholders all of its taxable income and gains. Distributions
determined in accordance with federal income tax regulations may differ in
amount or character from net investment income and realized gains for financial
reporting purposes. Financial reporting records are adjusted for permanent
book/tax differences to reflect tax character but are not adjusted for temporary
differences.
The fund files U.S. federal, state,
and local tax returns as required. The funds tax returns are subject to
examination by the relevant tax authorities until expiration of the applicable
statute of limitations, which is generally three years after the filing of the
tax return but which can be extended to six years in certain circumstances. Tax
returns for open years have incorporated no uncertain tax positions that require
a provision for income taxes.
Distributions during the years ended
December 31, 2013 and December 31, 2012, were characterized for tax purposes as
follows:
At December 31, 2013, the tax-basis
cost of investments and components of net assets were as follows:
The difference between book-basis and
tax-basis net unrealized appreciation (depreciation) is attributable to the
deferral of losses from wash sales and the realization of gains/losses on
passive foreign investment companies for tax purposes.
NOTE 5 - RELATED PARTY
TRANSACTIONS
The fund is managed by T. Rowe Price
Associates, Inc. (Price Associates), a wholly owned subsidiary of T. Rowe Price
Group, Inc. (Price Group). The investment management agreement between the fund
and Price Associates provides for an annual investment management fee equal to
0.65% of the funds average daily net assets. The fee is computed daily and paid
monthly.
In addition, the fund has entered
into service agreements with Price Associates and a wholly owned subsidiary of
Price Associates (collectively, Price). Price Associates computes the daily
share price and provides certain other administrative services to the fund. T.
Rowe Price Services, Inc., provides shareholder and administrative services in
its capacity as the funds transfer and dividend-disbursing agent. For the year
ended December 31, 2013, expenses incurred pursuant to these service agreements
were $90,000 for Price Associates and $2,000 for T. Rowe Price Services, Inc.
The total amount payable at period-end pursuant to these service agreements is
reflected as Due to Affiliates in the accompanying financial
statements.
The fund may invest in the T. Rowe
Price Reserve Investment Fund, the T. Rowe Price Government Reserve Investment
Fund, or the T. Rowe Price Short-Term Reserve Fund (collectively, the Price
Reserve Investment Funds), open-end management investment companies managed by
Price Associates and considered affiliates of the fund. The Price Reserve
Investment Funds are offered as short-term investment options to mutual funds,
trusts, and other accounts managed by Price Associates or its affiliates and are
not available for direct purchase by members of the public. The Price Reserve
Investment Funds pay no investment management fees.
Report of Independent Registered Public
Accounting Firm
To the Board of Directors of T.
Rowe Price Institutional Equity Funds, Inc. and
Shareholders of T. Rowe Price
Institutional Small-Cap Stock Fund
In our opinion, the accompanying
statement of assets and liabilities, including the portfolio of investments, and
the related statements of operations and of changes in net assets and the
financial highlights present fairly, in all material respects, the financial
position of T. Rowe Price Institutional Small-Cap Stock Fund (one of the
portfolios comprising T. Rowe Price Institutional Equity Funds, Inc., hereafter
referred to as the Fund) at December 31, 2013, and the results of its
operations, the changes in its net assets and the financial highlights for each
of the periods indicated therein, in conformity with accounting principles
generally accepted in the United States of America. These financial statements
and financial highlights (hereafter referred to as financial statements) are
the responsibility of the Funds management; our responsibility is to express an
opinion on these financial statements based on our audits. We conducted our
audits of these financial statements in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, and evaluating the overall
financial statement presentation. We believe that our audits, which included
confirmation of securities at December 31, 2013 by correspondence with the
custodian and brokers, and confirmation of the underlying funds by
correspondence with the transfer agent, provide a reasonable basis for
our opinion.
PricewaterhouseCoopers
LLP
Baltimore, Maryland
February 14, 2014
Tax Information (Unaudited) for the Tax Year Ended
12/31/13
|
We
are providing this information as required by the Internal Revenue Code. The
amounts shown may differ from those elsewhere in this report because of
differences between tax and financial reporting requirements.
The funds distributions to
shareholders included:
-
$11,557,000 from short-term capital
gains
-
$47,770,000 from long-term capital gains,
subject to the 15% rate gains category.
For taxable non-corporate
shareholders, $8,729,000 of the funds income represents qualified dividend
income subject to the 15% rate category.
For corporate shareholders,
$8,414,000 of the funds income qualifies for the dividends-received deduction.
Information on Proxy Voting Policies, Procedures, and
Records
|
A description of the policies and
procedures used by T. Rowe Price funds and portfolios to determine how to vote
proxies relating to portfolio securities is available in each funds Statement
of Additional Information. You may request this document by calling
1-800-225-5132 or by accessing the SECs website, sec.gov.
The description of our proxy voting
policies and procedures is also available on our website, troweprice.com. To
access it, click on the words Social Responsibility at the top of our
corporate homepage. Next, click on the words Conducting Business Responsibly
on the left side of the page that appears. Finally, click on the words Proxy
Voting Policies on the left side of the page that appears.
Each funds most recent annual proxy
voting record is available on our website and through the SECs website. To
access it through our website, follow the directions above to reach the
Conducting Business Responsibly page. Click on the words Proxy Voting
Records on the left side of that page, and then click on the View Proxy Voting
Records link at the bottom of the page that appears.
How to Obtain Quarterly Portfolio
Holdings
|
The fund files a complete schedule of
portfolio holdings with the Securities and Exchange Commission for the first and
third quarters of each fiscal year on Form N-Q. The funds Form N-Q is available
electronically on the SECs website (sec.gov); hard copies may be reviewed and
copied at the SECs Public Reference Room, 100 F St. N.E., Washington, DC 20549.
For more information on the Public Reference Room, call 1-800-SEC-0330.
About the Funds Directors and
Officers
|
Your fund is overseen by a Board of
Directors (Board) that meets regularly to review a wide variety of matters
affecting or potentially affecting the fund, including performance, investment
programs, compliance matters, advisory fees and expenses, service providers, and
business and regulatory affairs. The Board elects the funds officers, who are
listed in the final table. At least 75% of the Boards members are independent
of T. Rowe Price Associates, Inc. (T. Rowe Price), and its affiliates; inside
or interested directors are employees or officers of T. Rowe Price. The
business address of each director and officer is 100 East Pratt Street,
Baltimore, Maryland 21202. The Statement of Additional Information includes
additional information about the fund directors and is available without charge
by calling a T. Rowe Price representative at 1-800-638-5660.
Independent Directors
|
|
Name (Year of Birth)
Year Elected* [Number of
T. Rowe Price
Portfolios
Overseen]
|
|
Principal Occupation(s) and Directorships of Public Companies and
Other Investment Companies During the Past Five Years
|
|
|
|
William R. Brody, M.D., Ph.D. (1944)
2009 [157]
|
|
President
and Trustee, Salk Institute for Biological Studies (2009 to present);
Director, Novartis, Inc. (2009 to present); Director, IBM (2007 to
present); President and Trustee, Johns Hopkins University (1996 to 2009);
Chairman of Executive Committee and Trustee, Johns Hopkins Health System
(1996 to 2009)
|
|
|
|
Anthony W. Deering (1945)
2001 [157]
|
|
Chairman,
Exeter Capital, LLC, a private investment firm (2004 to present); Director
and Member of the Advisory Board, Deutsche Bank North America (2004 to
present); Director, Under Armour (2008 to present); Director, Vornado Real
Estate Investment Trust (2004 to 2012)
|
|
|
|
Donald W. Dick, Jr. (1943)
1996 [157]
|
|
Principal,
EuroCapital Partners, LLC, an acquisition and management advisory firm
(1995 to present)
|
|
|
|
Bruce
W. Duncan (1951)
2013 [157]
|
|
President,
Chief Executive Officer, and Director, First Industrial Realty Trust,
owner and operator of industrial properties (2009 to present); Chairman of
the Board (2005 to present), Interim Chief Executive Officer (2007), and
Director (1999 to present), Starwood Hotels & Resorts, a hotel and
leisure company; Senior Advisor, Kohlberg, Kravis, Roberts & Co. LP, a
global investment firm (2008 to 2009); Trustee, Starwood Lodging Trust, a
real estate investment trust and former subsidiary of Starwood (1995 to
2006)
|
|
|
|
Robert J. Gerrard, Jr. (1952)
2012 [157]
|
|
Advisory
Board Member, Pipeline Crisis/Winning Strategies (1997 to present);
Chairman of Compensation Committee and Director, Syniverse Holdings, Inc.
(2008 to 2011); Executive Vice President and General Counsel, Scripps
Networks, LLC (1997 to 2009)
|
|
|
|
Karen
N. Horn (1943)
2003 [157]
|
|
Senior
Managing Director, Brock Capital Group, an advisory and investment banking
firm (2004 to present); Director, Eli Lilly and Company (1987 to present);
Director, Simon Property Group (2004 to present); Director, Norfolk
Southern (2008 to present); Director, Fannie Mae (2006 to
2008)
|
|
|
|
Paul
F. McBride (1956)
2013 [157]
|
|
Former
Company Officer and Senior Vice President, Human Resources and Corporate
Initiatives (2004 to 2010)
|
|
|
|
Cecilia E. Rouse, Ph.D. (1963)
2012 [157]
|
|
Dean,
Woodrow Wilson School (2012 to present); Professor and Researcher,
Princeton University (1992 to present); Director, MDRC (2011 to present);
Member, National Academy of Education (2010 to present); Research
Associate, National Bureau of Economic Researchs Labor Studies Program
(1998 to 2009 and 2011 to present); Member, Presidents Council of
Economic Advisors (2009 to 2011); Member, The MacArthur Foundation Network
on the Transition to Adulthood and Public Policy (2000 to 2008); Member,
National Advisory Committee for the Robert Wood Johnson Foundations
Scholars in Health Policy Research Program (2008); Director and Member,
National Economic Association (2006 to 2008); Member, Association of
Public Policy Analysis and Management Policy Council (2006 to 2008);
Member, Hamilton Projects Advisory Board at The Brookings Institute (2006
to 2008); Chair of Committee on the Status of Minority Groups in the
Economic Profession, American Economic Association (2006 to 2008 and 2012
to present)
|
|
|
|
John
G. Schreiber (1946)
2001 [157]
|
|
Owner/President, Centaur Capital Partners, Inc., a real estate
investment company (1991 to present); Cofounder and Partner, Blackstone
Real Estate Advisors, L.P. (1992 to present); Director, General Growth
Properties, Inc. (2010 to present); Director, BXMT (formerly Capital
Trust, Inc.), a real estate investment company (2012 to present); Director
and Chairman of the Board, Brixmor Property Group, Inc. (2013 to
present)
|
|
|
|
Mark
R. Tercek (1957)
2009 [157]
|
|
President
and Chief Executive Officer, The Nature Conservancy (2008 to present);
Managing Director, The Goldman Sachs Group, Inc. (1984 to
2008)
|
|
*Each
independent director serves until retirement, resignation, or election of
a successor.
|
Inside Directors
|
|
Name (Year of Birth)
Year Elected* [Number of
T. Rowe Price
Portfolios
Overseen]
|
|
Principal Occupation(s) and Directorships of Public Companies and
Other Investment Companies During the Past Five Years
|
|
|
|
Edward C. Bernard (1956)
2006 [157]
|
|
Director and
Vice President, T. Rowe Price; Vice Chairman of the Board, Director, and
Vice President, T. Rowe Price Group, Inc.; Chairman of the Board,
Director, and President, T. Rowe Price Investment Services, Inc.; Chairman
of-the Board and Director, T. Rowe Price Retirement Plan Services, Inc.,
and T. Rowe Price Services, Inc.; Chairman of the Board, Chief Executive
Officer, and Director, T. Rowe Price International; Chairman of the Board,
Chief Executive Officer, Director, and President, T. Rowe Price Trust
Company; Chairman of the Board, all funds
|
|
|
|
Brian
C. Rogers, CFA, CIC (1955)
2006 [105]
|
|
Chief
Investment Officer, Director, and Vice President, T. Rowe Price; Chairman
of the Board, Chief Investment Officer, Director, and Vice President,
T. Rowe Price Group, Inc.; Vice President, T. Rowe Price Trust Company;
President, Institutional Equity Funds
|
|
*Each
inside director serves until retirement, resignation, or election of a
successor.
|
Officers
|
|
|
|
|
|
Name (Year of Birth)
Position Held With Institutional Equity
Funds
|
|
Principal Occupation(s)
|
|
|
|
Brian W.H. Berghuis, CFA (1958)
Executive
Vice President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
Anna M. Dopkin, CFA (1967)
Executive Vice President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., T. Rowe Price
International, and T. Rowe Price Trust Company
|
|
|
|
Roger L. Fiery III, CPA (1959)
Vice President
|
|
Vice
President, Price Hong Kong, Price Singapore, T. Rowe Price, T. Rowe Price
Group, Inc., T. Rowe Price International, and T. Rowe Price
Trust Company
|
|
|
|
Mark S. Finn, CFA, CPA (1963)
Executive Vice
President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
John R. Gilner (1961)
Chief Compliance Officer
|
|
Chief
Compliance Officer and Vice President, T. Rowe Price; Vice President, T.
Rowe Price Group, Inc., and T. Rowe Price Investment Services,
Inc.
|
|
|
|
Gregory S. Golczewski (1966)
Vice President
|
|
Vice
President, T. Rowe Price and T. Rowe Price Trust Company
|
|
|
|
Gregory K. Hinkle, CPA (1958)
Treasurer
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
Ann M. Holcomb, CFA (1972)
Vice President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
John D. Linehan, CFA (1965)
Executive Vice President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
Patricia B. Lippert (1953)
Secretary
|
|
Assistant Vice President, T. Rowe Price and T. Rowe Price
Investment Services, Inc.
|
|
|
|
Gregory A. McCrickard, CFA (1958)
Executive Vice
President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
David Oestreicher (1967)
Vice President
|
|
Director, Vice President, and Secretary, T. Rowe Price Investment
Services, Inc., T. Rowe Price Retirement Plan Services, Inc., T. Rowe
Price Services, Inc., and T. Rowe Price Trust Company; Chief Legal
Officer, Vice President, and Secretary, T. Rowe Price Group, Inc.; Vice
President and Secretary, T. Rowe Price and T. Rowe Price International;
Vice President, Price Hong Kong and Price Singapore
|
|
|
|
Larry J. Puglia, CFA, CPA (1960)
Executive Vice
President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
Deborah D. Seidel (1962)
Vice President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., T. Rowe Price
Investment Services, Inc., and T. Rowe Price Services,
Inc.
|
|
|
|
Robert W. Sharps, CFA, CPA (1971)
Executive
Vice President
|
|
Vice
President, T. Rowe Price, T. Rowe Price Group, Inc., and T. Rowe Price
Trust Company
|
|
|
|
J. David Wagner, CFA (1974)
Vice President
|
|
Vice
President, T. Rowe Price and T. Rowe Price Group, Inc.
|
|
|
|
John F. Wakeman (1962)
Vice President
|
|
Vice
President, T. Rowe Price and T. Rowe Price Group, Inc.
|
|
|
|
Julie L. Waples (1970)
Vice President
|
|
Vice
President, T. Rowe Price
|
|
Unless
otherwise noted, officers have been employees of T. Rowe Price or T. Rowe
Price International for at least 5 years.
|